In this study, we evaluated the antiproliferative activity on two human osteosarcoma cell lines (MG-63 and Saos2) of oleuropein, an olive oil compound traditionally found in the Mediterranean diet. Oleuropein exhibited obvious cytotoxic effects on human osteosarcoma cells in a concentration-and timedependent manner. Statistical analysis of IC 50 by the Probit regression method suggested that oleuropein had similar toxic effects on both cell lines tested (IC 50 range from 247.4-475.0 µM for MG63 cells and from 798.7-359.9 µM for Saos2 cells).
In olive (Olea europoea L.) leaves, the main phenolic compound is oleuropein, followed by hydroxytyrosol, the flavone-7-glucosides of luteolin and apigenin, and verbascoside [1a] . Antioxidative and antiproliferative properties of these compounds have been studied extensively, with a number of studies reporting that olive oil is more effective against cancer than other forms of added lipids [1b,c] . Olive oil intake has been shown to inversely correlate with the risk of breast cancer in humans [1d] and to reduce significantly precancerous lesions in colorectal cancer in vitro [2, 3] , prostate cancer [4] , leukemia [5] , pancreatic cancer [6] , hepatocellular carcinoma [7] , Hela cells [8a] , breast cancer [8b-g], thyroid cancer [9a] , urinary bladder carcinoma [8c], erythroleukemia/glioblastoma/ melanoma and renal cell adenocarcinoma [9b] . Although oleuropein has also been shown to have critical effects on the formation and maintenance of bones, and hence to remedy effectively bone-related conditions such as osteoporosis [9c], there is a lack of data related to other diseases such as osteosarcoma (OS). In this study, we investigated, for the first time, the antiproliferative effect of oleuropein on two human OS cell lines, MG-63 and Saos2. The effect of oleuropein was tested on two different human OS cell lines, which represent two different signs of osteoblastic maturity [9d].
Oleuropein caused 50% cell death in both human OS cell lines tested (MG-63 and Saos2), with IC 50 values of 346.3 and 419.7 μM in MG-63 and Saos2 OS cell lines, respectively, after 48 h of exposure. In this study, oleuroepin was shown to have a higher IC 50 value that previously calculated in studies in human promyelocytic leukemia cells HL60 (116.7 µM [10a] and 170 μM [10b], MCF-7 and MDA-MB-231 cells 110 and 160 μM, respectively [8c] . The dose of oleuropein used in our study was also higher than that previously described for HeLa human cervical carcinoma cells (200 µM) [8a] , thyroid cancer cells (100 µM) [9a] , and MDA-MB-231, MCF-10A and STO cells (25-75 µM), but similar to the dose used in cancer colon cells after 48 h treatment (400 µM) [2] , and prostate cancer cells after 72 h treatment (100-500 µM) [4] . The effect of oleuropein on cancer cells was extensively studied by Kikuchi and colleagues [10c], who tested its cytotoxicity against a panel of 39 human cancer cell lines, none of which represented bone cancers. The study against breast, central nervous system, colon, lung, melanoma, ovary, renal, stomach and prostate cancers showed a 492 Natural Product Communications Vol. 11 (4) 2016 Moran et al.
duration of exposure. In addition, the finding that the cytotoxicity differs between cell lines suggests that different molecular mechanisms may mediate the effects of oleuropein.
Experimental
General: Oleuropein was purchased from Sigma Chemicals (St. Louis, MO, USA). MG-63 and Saos2 (human OS) cell lines were obtained from Sigma-Aldrich (St. Louis, MO, USA). MG-63 cells were grown in EMEM (EBSS) supplemented with 10% heatinactivated fetal bovine serum (FBS), penicillin (10 U/mL), streptomycin (10 μg/mL), 2 mM glutamine and 1% non-essential amino acids (NEAA). Saos2 cells were grown in McCoy′s 5a supplemented with 10% heat-inactivated fetal bovine serum (FBS), penicillin (10 U/mL), streptomycin (10 μg/mL) and 2 mM glutamine. Cultures were incubated in the presence of 5% CO 2 at 37°C and 95% relative humidity.
Cytotoxicity assay:
The cells were seeded in 24-well plates with a density of 1×104 cells/well and incubated for 24 h at 37°C in 5% CO 2 . The cells were treated with different concentrations of oleuropein (50, 100, 200, 400 μM) . Untreated cancer cells were used as negative controls. After 24, 48 and 72 h of treatment, 100 µL of MTT reagent was added to each well. The plates were incubated at 37°C in 5% CO 2 for 4 h. Then, 100 mL of the solubilization solution was added to each well, followed by incubation for 1 h at 37ºC to dissolve formazan crystals. Finally, absorbance was read using an ELISA plate reader at a wavelength of 570 nm. The percentage of cytotoxicity and cell viability were calculated using the following equation: % Cytotoxicity=1-(mean absorbance of treated cells/mean absorbance of negative control) and % viability=100-% Cytotoxicity. IC 50 determinations: Probit analysis was used to determine the concentration at which lethality to oleuropein was 50% (IC 50 ) by the use of a maximum likelihood regression algorithm. The cytotoxicity values of IC 10 and IC 90 were also determined.
Statistical analysis:
All the data in this study represent mean ± SD of 3 replicates of identical experiments. Normality of the data was determined by the Kolmogorov-Smirnov test. Statistical significance was determined by ANOVA followed by Bonferroni's test, and a P-value ≤0.05 was considered statistically significant. Data were plotted as percentages of control vs. logarithmic chemical concentration in μM.
